{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:21:40Z","timestamp":1759159300051,"version":"3.41.0"},"reference-count":33,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,12]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The prevalence of food allergies, particularly IgE-mediated allergies, is rising in developed countries, with cashew nut allergy emerging as a significant public health concern due to its potential for severe anaphylaxis and frequent association with atopic disorders. Cashew nuts are among the most common allergens in Europe and Australia, often involving cosensitisation with pistachios, hazelnuts and other allergens. Diagnosis relies on clinical history, measurement of specific IgE (sIgE) levels, skin prick tests (SPT) and oral food challenges (OFCs). Current management strategies focus on allergen avoidance and emergency interventions, whereas oral immunotherapy (OIT) represents a promising approach to desensitisation. Recent studies, including the NUT CRACKER trial, have reported high desensitisation rates with cashew OIT, although these are associated with a risk of adverse events. This study introduces a novel randomised controlled trial aimed at evaluating the efficacy and safety of cashew immunotherapy in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>This randomised, open-label, parallel-group trial, with a 2:1 allocation ratio, will be conducted at the Department of Paediatric Pneumology and Allergology, Medical University of Warsaw, Poland. Thirty-nine children, aged 4\u201317 years, with confirmed IgE-mediated cashew allergy via open OFC will be enrolled. Participants in the experimental group will undergo OIT, which involves gradually increasing doses of cashew protein up to a maintenance dose of 1200\u2009mg. The duration of OIT will range from 12 to 60 weeks, depending on individual baseline tolerance. The control group will receive standard management, including strict cashew avoidance and emergency response strategies to accidental exposure, for 1 year.<\/jats:p><jats:p>The primary endpoint is to determine the proportion of participants tolerating a 4043\u2009mg dose of cashew protein at the study\u2019s end in the OIT group compared with the control group. Secondary outcomes include evaluating the safety profile of OIT, assessing changes in laboratory markers such as sIgE and IgG4 levels for cashew and the major cashew allergen Ana o 3, analysing basophil activation test responses and measuring changes in SPT wheal diameter at baseline and study completion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The study has been approved by the Ethics Committee of the Medical University of Warsaw (approval number: KB\/267\/2023). Study findings will be published in peer-reviewed journals and presented at international conferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06328504\">NCT06328504<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2025-101139","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:55:37Z","timestamp":1751424937000},"page":"e101139","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of cashew nut protein immunotherapy: protocol for a single-centre randomised controlled trial in a Polish paediatric population"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct06328504","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Agnieszka","family":"Szczukocka","sequence":"first","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Pietrzyk-Kozi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Zieli\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Krupa-\u0141aska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Krejner-Bienias","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kulus","sequence":"additional","affiliation":[{"name":"Medical University of Warsaw, Warszawa, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-104X","authenticated-orcid":false,"given":"Katarzyna","family":"Grzela","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2025070119552450000_15.7.e101139.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.10.018"},{"key":"2025070119552450000_15.7.e101139.2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11882-023-01120-y","article-title":"Epidemiology and the Growing Epidemic of Food Allergy in Children and Adults Across the Globe","volume":"24","author":"Warren","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"2025070119552450000_15.7.e101139.3","doi-asserted-by":"publisher","DOI":"10.1111\/all.12429"},{"key":"2025070119552450000_15.7.e101139.4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jaci.2019.09.036","article-title":"Defining challenge-proven coexistent nut and sesame seed allergy: A prospective multicenter European study","volume":"145","author":"Brough","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2025070119552450000_15.7.e101139.5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/apa.12687","article-title":"Ten-year review reveals changing trends and severity of allergic reactions to nuts and other foods","volume":"103","author":"Johnson","year":"2014","journal-title":"Acta Paediatr"},{"key":"2025070119552450000_15.7.e101139.6","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.115755"},{"key":"2025070119552450000_15.7.e101139.7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.anai.2020.01.024","article-title":"Prevalence and natural history of tree nut allergy","volume":"124","author":"McWilliam","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025070119552450000_15.7.e101139.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.09.002"},{"key":"2025070119552450000_15.7.e101139.9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.aller.2019.07.005","article-title":"Phenotypical characterization of tree nuts and peanut allergies in east Mediterranean children","volume":"48","author":"Cetinkaya","year":"2020","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2025070119552450000_15.7.e101139.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151055","article-title":"Multicentre Double-Blind Placebo-Controlled Food Challenge Study in Children Sensitised to Cashew Nut","volume":"11","author":"van der Valk","year":"2016","journal-title":"PLoS ONE"},{"key":"2025070119552450000_15.7.e101139.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100641","article-title":"Recent advances in diagnosing and managing nut allergies with focus on hazelnuts, walnuts, and cashew nuts","volume":"15","author":"Borres","year":"2022","journal-title":"World Allergy Organ J"},{"key":"2025070119552450000_15.7.e101139.12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1398-9995.1998.tb03946.x","article-title":"Pectin and cashew nut allergy: cross-reacting allergens?","volume":"53","author":"R\u00e4s\u00e4nen","year":"1998","journal-title":"Allergy"},{"key":"2025070119552450000_15.7.e101139.13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1081-1206(10)60966-0","article-title":"Pectin anaphylaxis and possible association with cashew allergy","volume":"97","author":"Ferdman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025070119552450000_15.7.e101139.14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.alit.2021.07.006","article-title":"Anaphylaxis in a pectin- and cashew nut-allergic child caused by a citrus bath","volume":"71","author":"Washio","year":"2022","journal-title":"Allergol Int"},{"key":"2025070119552450000_15.7.e101139.15","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1016\/j.jaip.2023.07.019","article-title":"Cashew Allergy Prevalence and Sensitization in 1-Year-Old Infants","volume":"11","author":"Brettig","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025070119552450000_15.7.e101139.16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5114\/ada.2022.124730","article-title":"Prevalence of nut allergen sensitization among children in central Poland","volume":"40","author":"Chojnowska-W\u00f3jtowicz","year":"2023","journal-title":"Postepy Dermatol Alergol"},{"key":"2025070119552450000_15.7.e101139.17","unstructured":"INC (2023). Nuts &amp; Dried Fruits Statistical Yearbook 2022\/23. Tarragona, Spain: International Nut &amp; Dried Fruit Council."},{"key":"2025070119552450000_15.7.e101139.18","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jaci.2005.02.028","article-title":"Ana o 3, an important cashew nut (Anacardium occidentale L.) allergen of the 2S albumin family","volume":"115","author":"Robotham","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2025070119552450000_15.7.e101139.19","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.125208"},{"key":"2025070119552450000_15.7.e101139.20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000073262","article-title":"Ana o 2, a major cashew (Anacardium occidentale L.) nut allergen of the legumin family","volume":"132","author":"Wang","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"2025070119552450000_15.7.e101139.21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/cea.13150","article-title":"Threshold dose distribution for cashew nut allergy in children","volume":"48","author":"Divaret-Chauveau","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"2025070119552450000_15.7.e101139.22","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1111\/all.15902","article-title":"EAACI guidelines on the diagnosis of IgE-mediated food allergy","volume":"78","author":"Santos","year":"2023","journal-title":"Allergy"},{"key":"2025070119552450000_15.7.e101139.23","doi-asserted-by":"publisher","DOI":"10.1111\/all.13319"},{"key":"2025070119552450000_15.7.e101139.24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/all.15212","article-title":"Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study)","volume":"77","author":"Elizur","year":"2022","journal-title":"Allergy"},{"key":"2025070119552450000_15.7.e101139.25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2023.11.750","article-title":"Cashew Oral Immunotherapy Outcomes in Infants and Toddlers","volume":"153","author":"Jacobs","year":"2024","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"2025070119552450000_15.7.e101139.26","doi-asserted-by":"crossref","DOI":"10.57187\/s.3691","article-title":"Safety of oral immunotherapy for cashew nut and peanut allergy in children - a retrospective single-centre study","volume":"154","author":"Breiding","year":"2024","journal-title":"Swiss Med Wkly"},{"key":"2025070119552450000_15.7.e101139.27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00005-015-0328-z","article-title":"Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma","volume":"63","author":"Grzela","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2025070119552450000_15.7.e101139.28","doi-asserted-by":"crossref","unstructured":"Yilmaz O , Tunca S , Yasar A , et al . Inflammatory markers in exhaled breath condensate in nonasthmatic children with food allergy. J Breath Res 2023;18. doi:10.1088\/1752-7163\/ad02b5","DOI":"10.1088\/1752-7163\/ad02b5"},{"key":"2025070119552450000_15.7.e101139.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.10.017"},{"key":"2025070119552450000_15.7.e101139.30","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/all.13810","article-title":"Food allergy endotype with high risk of severe anaphylaxis in children-Monosensitization to cashew 2S albumin Ana o 3","volume":"74","author":"Blazowski","year":"2019","journal-title":"Allergy"},{"key":"2025070119552450000_15.7.e101139.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2010.03454.x"},{"key":"2025070119552450000_15.7.e101139.32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2500\/jfa.2022.4.220030","article-title":"Approaches to maintenance dosing during oral immunotherapy","volume":"4","author":"Inamdar","year":"2022","journal-title":"J Food Allergy"},{"key":"2025070119552450000_15.7.e101139.33","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12268","article-title":"Efficacy and safety of oral immunotherapy for peanut, cow\u2019s milk, and hen\u2019s egg allergy: A systematic review of randomized controlled trials","volume":"13","author":"Lodge","year":"2023","journal-title":"Clin Transl Allergy"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-101139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:55:42Z","timestamp":1751424942000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-101139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,1]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjopen-2025-101139"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-101139","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}